30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Aardvark Therapeutics Inc (AARD)

Track

The most recent insider trading activity occurred on December 11, 2025, with two BUY transactions totaling $144,595.00. Prior to this, significant BUY transactions by executives and a 10% stockholder were noted in September 2025. Earlier in February 2025, substantial BUYs were made by a former 10% owner and a fund.
Stock chart
Ticker: AARD Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Sun Nelson
Chief Financial Officer
1 purchase — total 43,200 USD
Buy 11 Dec 2025
Value US$4,910,496.53 | Price 117.44 | Shares 30,626
Buy 11 Dec 2025
Value US$2,855,285.31 | Price 324.46 | Shares 26,598
Buy 15 Sep 2025
Value US$34,804.70 | Price 9.94 | Shares 3,500
Buy 15 Sep 2025
Value US$61,818.90 | Price 9.51 | Shares 6,500
Proposed sale 15 Sep 2025
Value US$93,413.01 | Price 9.02 | Shares 10,360
Buy 12 Sep 2025
Value US$42,515.50 | Price 8.50 | Shares 5,000
Buy 11 Sep 2025
Value US$46,926.00 | Price 7.82 | Shares 6,000
Buy 10 Sep 2025
Value US$71,212.50 | Price 7.91 | Shares 9,000
Buy 9 Sep 2025
Value US$48,439.80 | Price 8.07 | Shares 6,000
Proposed sale 2 Sep 2025
Value US$170,118.00 | Price 8.51 | Shares 20,000
Proposed sale 28 Aug 2025
Value US$241,565.21 | Price 8.72 | Shares 27,691
Buy 14 Feb 2025
Value US$10,000,000.00 | Price 16.00 | Shares 625,000
Buy 14 Feb 2025
Value US$10,000,000.00 | Price 16.00 | Shares 625,000
Buy 14 Feb 2025
Value US$160,000.00 | Price 16.00 | Shares 10,000
Buy 14 Feb 2025
Value US$264,672.00 | Price 16.00 | Shares 16,542
Buy 14 Feb 2025
Value US$3,000,000.00 | Price 16.00 | Shares 187,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-12 2025-12-11 B Purchase
3.0
Sun Nelson

Chief Financial Officer

Officer
30,626 -26.3%
117.44
US$4,910,497 		30,626 -26.3% 117.44 US$4,910,497
2025-12-12 2025-12-11 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
26,598 -16.1%
324.46
US$2,855,285 		26,598 -16.1% 324.46 US$2,855,285
2025-09-16 2025-09-15 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
49,118 +20.3%
47.79
US$1,815,775 		49,118 +20.3% 47.79 US$1,815,775
2025-09-16 2025-09-15 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
6,500 +0.4%
9.51
US$61,819 		6,500 +0.4% 9.51 US$61,819
2025-09-15 2025-09-15 PrS Proposed sale
VICKERS VENT GLB DEEP-TECH FND I LP

Director; 10% Stockholder

Non-Executive Director Large shareholder
10,360
9.02
US$93,413 		10,360 9.02 US$93,413
2025-09-12 2025-09-12 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
5,000 +0.3%
8.50
US$42,516 		5,000 +0.3% 8.50 US$42,516
2025-09-12 2025-09-11 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
6,000 +0.4%
7.82
US$46,926 		6,000 +0.4% 7.82 US$46,926
2025-09-12 2025-09-10 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
9,000 +0.6%
7.91
US$71,212 		9,000 +0.6% 7.91 US$71,212
2025-09-10 2025-09-09 B Purchase
3.0
Sun Nelson

Chief Financial Officer

Officer
6,000 +6.0%
8.07
US$48,440 		6,000 +6.0% 8.07 US$48,440
2025-09-02 2025-09-02 PrS Proposed sale
VICKERS VENT GLB DEEP-TECH FND I LP

Director; 10% Stockholder

Non-Executive Director Large shareholder
20,000
8.51
US$170,118 		20,000 8.51 US$170,118
2025-08-28 2025-08-28 PrS Proposed sale
VICKERS VENT GLB DEEP-TECH FND I LP

Director; 10% Stockholder

Non-Executive Director Large shareholder
27,691
8.72
US$241,565 		27,691 8.72 US$241,565
2025-02-19 2025-02-14 B Purchase
Decheng Capital Global Life Sciences Fund IV, L.P.
Large shareholder
625,000 +187.5%
16.00
US$10,000,000 		625,000 +187.5% 16.00 US$10,000,000
2025-02-19 2025-02-14 B Purchase
Decheng Capital Global Life Sciences Fund IV, L.P.
Large shareholder
625,000 +26.8%
16.00
US$10,000,000 		625,000 +26.8% 16.00 US$10,000,000
2025-02-19 2025-02-14 B Purchase
3.0
Sun Nelson

Chief Financial Officer

Officer
10,000 +11.2%
16.00
US$160,000 		10,000 +11.2% 16.00 US$160,000
2025-02-19 2025-02-14 B Purchase
3.7
Lee Tien-Li

Chief Executive Officer

Executive Director Large shareholder
16,542 +1.1%
16.00
US$264,672 		16,542 +1.1% 16.00 US$264,672
2025-02-19 2025-02-14 B Purchase
3.8
Cormorant Asset Management, LP

Former 10% Owner
187,500 +23.4%
16.00
US$3,000,000 		187,500 +23.4% 16.00 US$3,000,000
Explore more

More insider trading research around Aardvark Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America